ATE352569T1 - Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält - Google Patents

Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält

Info

Publication number
ATE352569T1
ATE352569T1 AT97932347T AT97932347T ATE352569T1 AT E352569 T1 ATE352569 T1 AT E352569T1 AT 97932347 T AT97932347 T AT 97932347T AT 97932347 T AT97932347 T AT 97932347T AT E352569 T1 ATE352569 T1 AT E352569T1
Authority
AT
Austria
Prior art keywords
alpha
separating
paste containing
containing fractions
proteinase inhibitor
Prior art date
Application number
AT97932347T
Other languages
English (en)
Inventor
Duk Sung Hwang
Evelyn Nario
Mark Lepe
Lyndon Luz
Hirokazu Ito
Kazuo Takechi
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24701177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE352569(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Application granted granted Critical
Publication of ATE352569T1 publication Critical patent/ATE352569T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Meat, Egg Or Seafood Products (AREA)
AT97932347T 1996-07-01 1997-06-27 Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält ATE352569T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/673,064 US5616693A (en) 1996-07-01 1996-07-01 Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste

Publications (1)

Publication Number Publication Date
ATE352569T1 true ATE352569T1 (de) 2007-02-15

Family

ID=24701177

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97932347T ATE352569T1 (de) 1996-07-01 1997-06-27 Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält
AT06025342T ATE420111T1 (de) 1996-07-01 1997-06-27 Verfahren zur trennung des alpha-1- proteinaseinhibitors von cohn-fraktion iv1+iv4- paste

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06025342T ATE420111T1 (de) 1996-07-01 1997-06-27 Verfahren zur trennung des alpha-1- proteinaseinhibitors von cohn-fraktion iv1+iv4- paste

Country Status (16)

Country Link
US (2) US5616693A (de)
EP (2) EP1762576B1 (de)
JP (3) JP4390855B2 (de)
KR (1) KR20000022480A (de)
AT (2) ATE352569T1 (de)
AU (1) AU726233B2 (de)
BR (1) BR9710107B1 (de)
CA (2) CA2259499C (de)
CZ (3) CZ302102B6 (de)
DE (2) DE69737294T2 (de)
DK (2) DK0944392T3 (de)
ES (2) ES2320919T3 (de)
IL (1) IL127774A (de)
PL (3) PL188830B1 (de)
PT (2) PT1762576E (de)
WO (1) WO1998000154A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AU3511500A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US6462180B1 (en) 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
CA2432641A1 (en) 2000-12-14 2002-06-20 Bayer Corporation Method of preparing alpha-1 proteinase inhibitor
KR100406870B1 (ko) * 2001-05-25 2003-11-21 주식회사 두산 침전법을 이용한 계란 난황에서의 유용 수용성 성분의분리방법 및 침전 부산물의 이용 방법
WO2003014339A2 (en) * 2001-08-07 2003-02-20 Novozymes, A/S Carbohydrates and polyols for dissolving protein crystals
EP1520012B1 (de) * 2002-07-01 2009-01-07 Novozymes A/S Monopropylenglykol als fermentationszusatz
US7777006B2 (en) * 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
US7850970B2 (en) * 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
US7807435B2 (en) * 2005-08-11 2010-10-05 Baxter International Inc. Method for the purification of alpha-1 proteinase inhibitor (a1PI)
GB0524432D0 (en) * 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
US20080124303A1 (en) * 2005-12-12 2008-05-29 Cavit Sciences, Inc Methods and compositions for treatment of viral infections
EP1999262B1 (de) * 2006-03-30 2012-09-26 Baxter International Inc. Verfahren zur reinigung von rekombinantem alpha 1-antitrypsin mit anionenaustausch-chromatografie-schritt
WO2007134800A1 (en) * 2006-05-19 2007-11-29 Baxter International Inc. Ethanol dependence of alpha1 antitrypsin c-terminal lys truncation by basic carboxypeptidases
CA2836478A1 (en) 2011-05-27 2012-12-06 Baxter International Inc. Therapeutic protein conjugated to water-soluble polymers via reduced cysteine sulfhydryl group
EP2723370A4 (de) 2011-06-24 2015-06-03 Univ Colorado Regents Zusammensetzungen, verfahren und verwendung für alpha-1-antitrypsin-fusionsmoleküle
KR20140137347A (ko) 2012-01-10 2014-12-02 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
CA2943938A1 (en) 2013-03-29 2014-10-02 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for preparing a subject for organ or non-organ implantation
IL267923B2 (en) 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2770616A (en) * 1951-01-29 1956-11-13 Protein Foundation Inc Fractionation of proteinaceous materials in blood plasma and liver tissue
US2761808A (en) * 1952-09-06 1956-09-04 Ortho Pharma Corp Plasma fractionation process
US4056614A (en) * 1972-09-22 1977-11-01 Marc Bonneau Immunity depressant medicine
JPS52128205A (en) * 1976-04-16 1977-10-27 Green Cross Corp:The Prophylactic and therapeutic drugs for cerebro-vascular contraction
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4439358A (en) * 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4697003A (en) * 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
JPS6317899A (ja) * 1986-07-09 1988-01-25 Green Cross Corp:The ハプトグロビンの精製方法
JPS63132898A (ja) * 1986-11-26 1988-06-04 Meito Sangyo Kk 蛋白質の分離精製方法
US5093316A (en) * 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
US4829054A (en) * 1987-04-13 1989-05-09 Miles Laboratories, Inc. Method of decreasing lung damage in a host following the onset of gram negative septicemia/endotoxemia
EP0288841B1 (de) * 1987-04-27 1992-12-30 Miles Inc. Verfahren zur Herstellung von hochgereinigtem alpha-1-Proteinase-Inhibitor
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
US5073487A (en) * 1989-01-30 1991-12-17 Athens Research And Technology, Inc. Rapid assay for functional human α1 -proteinase inhibitor
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5610285A (en) * 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste

Also Published As

Publication number Publication date
PT944392E (pt) 2007-04-30
ES2281104T3 (es) 2007-09-16
DE69737294D1 (de) 2007-03-15
DK1762576T3 (da) 2009-04-20
US5981715A (en) 1999-11-09
US5616693A (en) 1997-04-01
EP0944392A4 (de) 2004-11-24
PL330934A1 (en) 1999-06-07
DK0944392T3 (da) 2007-04-23
EP1762576A1 (de) 2007-03-14
AU3583197A (en) 1998-01-21
JP2008120822A (ja) 2008-05-29
CZ301332B6 (cs) 2010-01-20
CZ435698A3 (cs) 1999-05-12
BR9710107B1 (pt) 2009-05-05
BR9710107A (pt) 1999-08-10
CA2259499C (en) 2006-01-24
IL127774A0 (en) 1999-10-28
EP1762576B1 (de) 2009-01-07
JP4588770B2 (ja) 2010-12-01
IL127774A (en) 2005-08-31
PL188873B1 (pl) 2005-05-31
PL188874B1 (pl) 2005-05-31
ATE420111T1 (de) 2009-01-15
JP4390855B2 (ja) 2009-12-24
CZ302102B6 (cs) 2010-10-13
CZ300452B6 (cs) 2009-05-20
EP0944392B1 (de) 2007-01-24
AU726233B2 (en) 2000-11-02
DE69739212D1 (de) 2009-02-26
PT1762576E (pt) 2009-02-02
WO1998000154A1 (en) 1998-01-08
DE69737294T2 (de) 2007-07-12
JP2009191076A (ja) 2009-08-27
JP2000514647A (ja) 2000-11-07
KR20000022480A (ko) 2000-04-25
JP5245079B2 (ja) 2013-07-24
PL188830B1 (pl) 2005-04-29
EP0944392A1 (de) 1999-09-29
CA2259499A1 (en) 1998-01-08
ES2320919T3 (es) 2009-05-29
CA2489773A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
ATE352569T1 (de) Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält
ATE250066T1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE69707033D1 (de) Verfahren zur Behandlung von Gasen die Organohalogenzusammensetzungen enthalten
ATE195503T1 (de) Verfahren zur destillation von alkoholen
DE69004353D1 (de) Verfahren zur Reinigung von Tryptophan.
DE69121502D1 (de) Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
DE3763601D1 (de) Verfahren zum isolieren und reinigen von haemin.
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE69233451D1 (de) Ein verfahren zur herstellung therapeutisch wirksamer bruchstücke von von willebrand-faktor
ATE171875T1 (de) Entzündungshemmender faktor, verfahren zur isolation und verwendung
DE69829066D1 (de) Verfahren zur reinigung von alkanolaminen
ATE270275T1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren
DE69300901D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan.
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
ATE86618T1 (de) Verfahren zur abtrennung von aldehydischen verunreinigungen aus ethylenoxid.
DE69736180D1 (de) Behandlung von manischen erkrankungen
DE69614936D1 (de) d4T polymorphe Form I Verfahren
ATE84041T1 (de) Verfahren zur herstellung von hochgereinigtem alpha-1-proteinase-inhibitor.
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung
DE50008776D1 (de) Verfahren zur gewinnung von bakteriorhodopsin
DE59503639D1 (de) Verfahren zum chemischen modifizieren von alkylgruppenhaltigen flüssigkeiten
DE69011065D1 (de) Verfahren zur Behandlung von Nickel-Magnesium-Silikaterzen.
DE69026912D1 (de) Verfahren zur Herstellung von Nojirimycin-Verbindungen
ATE254610T1 (de) Verfahren zur selektiven alkylierung von epoxyalkoholen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0944392

Country of ref document: EP